<DOC>
	<DOC>NCT00529542</DOC>
	<brief_summary>The purpose of this study is to determine the efficacy of Lipitor (Atorvastatin) for the treatment of PCOS with elevated LDL cholesterol.</brief_summary>
	<brief_title>A Trial of Lipitor (Atorvastatin) for the Treatment of Polycystic Ovary Syndrome (PCOS) in Women With Elevated Low-density Lipoprotein (LDL) Cholesterol</brief_title>
	<detailed_description>The investigators hypothesize that improving the lipid profile with atorvastatin will improve vascular function, increase the frequency of ovulation, decrease androgen levels, improve insulin sensitivity, and improve the lipid profile more efficiently than placebo.</detailed_description>
	<mesh_term>Syndrome</mesh_term>
	<mesh_term>Polycystic Ovary Syndrome</mesh_term>
	<mesh_term>Atorvastatin Calcium</mesh_term>
	<criteria>Women with PCOS 8 or fewer menstrual periods per year elevated serum total testosterone elevated LDL cholesterol current pregnancy or breastfeeding current use of oral contraceptives, progestins insulin sensitizing medications thyroid disease, hyperprolactinemia, active liver disease, type 1 or type 2 diabetes</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>40 Years</maximum_age>
	<verification_date>September 2014</verification_date>
	<keyword>Polycystic Ovary Syndrome</keyword>
</DOC>